Document Detail

Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs.
MedLine Citation:
PMID:  21273054     Owner:  NLM     Status:  Publisher    
Pulmonary arterial hypertension is a progressive, fatal disease characterized by elevated pulmonary arterial pressure ≥25mmHg and normal pulmonary capillary wedge pressure ≤15mmHg. Physiological features of pulmonary arterial hypertension are characterized clinically by the presence of pre-capillary pulmonary hypertension not caused by other conditions such as lung diseases or chronic thromboembolic pulmonary hypertension. There are several therapies currently available that have been shown to improve hemodynamics and improve outcomes in patients with pulmonary arterial hypertension. These therapies include synthetic prostacyclin and prostaglandin analogs, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors. Multiple prostacyclin and prostaglandin analog formulations are currently in use (both branded and generic), available for parenteral, inhaled, or oral administration. This review discusses the pharmacology, clinical effects, and routes of administration of prostacyclin and prostaglandin analogs, emphasizing the advantages and disadvantages of each from the clinical perspective.
Zeenat Safdar
Related Documents :
21800374 - Reappraising the surface anatomy of the pterion and its relationship to the middle meni...
935484 - Observations of radionuclide imaging in hypertrophic pulmonary osteoarthropathy.
25275794 - Septum primum malposition defect and inferior sinus venosus defect: a rare association.
25463334 - Aortitis and aortic occlusion in crohn's disease.
19935604 - Can ivus-virtual histology improve outcomes of percutaneous carotid treatment?
23899814 - Takutsubo cardiomyopathy and flash pulmonary edema in a trauma patient.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-25
Journal Detail:
Title:  Respiratory medicine     Volume:  -     ISSN:  1532-3064     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Baylor College of Medicine, 6620 Main Street, Suite 11B.09, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of...
Next Document:  The protective effects of nutritional antioxidant therapy on Ehrlich solid tumor-bearing mice depend...